This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep 25;10(9):e0139104.
doi: 10.1371/journal.pone.0139104. eCollection 2015.

Infection by Toxoplasma gondii Induces Amoeboid-Like Migration of Dendritic Cells in a Three-Dimensional Collagen Matrix

Affiliations

Infection by Toxoplasma gondii Induces Amoeboid-Like Migration of Dendritic Cells in a Three-Dimensional Collagen Matrix

Sachie Kanatani et al. PLoS One. .

Abstract

Toxoplasma gondii, an obligate intracellular parasite of humans and other warm-blooded vertebrates, invades a variety of cell types in the organism, including immune cells. Notably, dendritic cells (DCs) infected by T. gondii acquire a hypermigratory phenotype that potentiates parasite dissemination by a 'Trojan horse' type of mechanism in mice. Previous studies have demonstrated that, shortly after parasite invasion, infected DCs exhibit hypermotility in 2-dimensional confinements in vitro and enhanced transmigration in transwell systems. However, interstitial migration in vivo involves interactions with the extracellular matrix in a 3-dimensional (3D) space. We have developed a collagen matrix-based assay in a 96-well plate format that allows quantitative locomotion analyses of infected DCs in a 3D confinement over time. We report that active invasion of DCs by T. gondii tachyzoites induces enhanced migration of infected DCs in the collagen matrix. Parasites of genotype II induced superior DC migratory distances than type I parasites. Moreover, Toxoplasma-induced hypermigration of DCs was further potentiated in the presence of the CCR7 chemotactic cue CCL19. Blocking antibodies to integrins (CD11a, CD11b, CD18, CD29, CD49b) insignificantly affected migration of infected DCs in the 3D matrix, contrasting with their inhibitory effects on adhesion in 2D assays. Morphological analyses of infected DCs in the matrix were consistent with the acquisition of an amoeboid-like migratory phenotype. Altogether, the present data show that the Toxoplasma-induced hypermigratory phenotype in a 3D matrix is consistent with integrin-independent amoeboid DC migration with maintained responsiveness to chemotactic and chemokinetic cues. The data support the hypothesis that induction of amoeboid hypermigration and chemotaxis/chemokinesis in infected DCs potentiates the dissemination of T. gondii.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Experimental set-up for DC migration in a 3D collagen matrix.
(A) Schematic representation of the assay set-up with collagen matrix as indicated under Materials and Methods. DCs were maintained in complete medium (CM) and allowed to sediment on the top of the collagen matrix layer in 96-well plates. After 18 h incubation, the localization of DAPI-labeled DCs in the collagen gel was analyzed by confocal microscopy in 200 z-optical sections as indicated. (B) Plots represent, for each condition, the 3D reconstruction assembly of z-stacks as indicated under Materials and Methods. Colored structures indicate the localization of individual DCs (DAPI) at indicated time points ± cytochalasin D (CytD). (C) Dot plots represent the distribution of migrated distances for the different conditions. For each condition, 100 single cells were randomly selected and analyzed from one representative donor. Bar indicates mean migrated distance. Asterisks indicate significant differences (***: P < 0.001; non-significant (ns): P > 0.05 Kruskal-Wallis test, Dunnett ́s test). (D) Mean migrated distances by DCs under same conditions as in B and C. Data represent compiled analysis of 500 randomly chosen cells per donor from 5 different donors. Bars indicate mean migrated distances (***: P < 0.001, ns: P > 0.05; Two-way ANOVA, Tukey ́s HSD test).
Fig 2
Fig 2. Migration in a 3D-matrix by DCs challenged with T. gondii.
(A and B) Histograms represent the distribution of migrated distances for (A) unchallenged DCs in complete medium and (B) DCs pre-challenged with T. gondii (PRU-RFP, type II, MOI 3, 4h) as indicated under Materials and Methods. Arrows indicate, for each condition, the percentage (%) of cells in the matrix migrating < 80 μm or > 80 μm, respectively. 500 randomized cells from one representative donor are shown. The experiments were performed with DCs from 5 donors with similar results. Inset plots represent, for each condition, the 3D reconstruction assembly of z-stacks for the total cell population as indicated under Materials and Methods. (C) Mean migrated distances by unchallenged DCs and DCs challenged with T. gondii (PRU-RFP, type II), from 5 different donors. Data represent compiled analysis of 500 randomly chosen cells per donor. Bars indicate mean migrated distances. (***: P < 0.001; Paired t-test, Holm ́s correction). (D) Dot plots represent the distribution of migrated distances of individual DCs challenged with T. gondii (type I: LDMluc; type II: PRU-RFP) related to unchallenged DCs. Bars indicate mean migrated distances. For each condition, 100 randomly chosen cells from one representative donor are shown. Significant differences were observed for challenged DCs (type I and II) versus unchallenged DCs (**: P < 0.01; Kruskal-Wallis test, Dunnett ́s test). Performed with 3 donors with similar results. (E) Mean migrated distances of DCs challenged with T. gondii (type I: LDMluc; type II: PRU-RFP) as in (B) from 3 different donors. Data represent compiled analysis of 500 randomly chosen cells per donor. Bars indicate mean migrated distances. (*: P < 0.05; Paired t-test, Holm ́s correction). (F) Mean migrated distances of DCs challenged with T. gondii (PRU-RFP, type II) as in (B) at indicated time points ± cytochalasin D (CytD). Data represent compiled analysis of 500 cells randomly chosen cells per donor from 3 different donors. (**: P < 0.01, ns: P > 0.05; Two-way ANOVA, Tukey ́s HSD test).
Fig 3
Fig 3. Morphological characteristics and migration of Toxoplasma-infected DCs and non-infected DCs in the 3D matrix.
(A) Representative micrographs in maximum intensity projection of unchallenged DCs in complete medium (CM, left), Challenged/By-stander DCs (middle) and Challenged/T. gondii DCs (right; PTG-GFP type II, MOI 3, green) in a 3D collagen matrix, stained with DAPI (blue), and Alexa Fluor 594-Phalloidin (red) to detect F-actin as indicated under Materials and Methods. In the middle micrograph, arrow indicates non-infected DC surrounded by an infected DC (green + red) and two extracellular T. gondii tachyzoites (green). Scale bars = 10 μm. (B) Graph shows, for each condition, the percentage of cells (mean ±SEM) that exhibit rounded phenotype, absence of membrane extensions and veils, respectively, related to the total cell population. The morphological criteria are specified under Materials and Methods. For each condition, a total of 50 cells/donor were analyzed from 3 different donors. (*: P < 0.05, **: P < 0.01, ns: P > 0.5, Paired t-test, Holm ́s correction). (C) Compiled mean scores (± SD) based on morphological criteria as in (B). For each condition, a total of 50 cells/donor were analyzed from 3 different donors (*: P < 0.05, **: P < 0.01, Paired t-test, Holm ́s correction). (D) Distribution of the total scores (% of total cell population) based on morphological criteria specified under Materials and Methods. For each condition, a total of 50 cells/donor from 3 donors were assessed. Significant differences were observed between tachyzoite-infected DCs and non-infected DCs (P < 0.0001; Fisher ́s exact test) or by-stander DCs (P < 0.0001), while differences between non-infected DCs and by-stander DCs were non-significant (P > 0.05). (E) Representative 3D projection analysis of DCs challenged with T. gondii (PTG-GFP type II). The colored spheres indicate the position of cells in the defined 3D space. Infected cells and non-infected cells were defined and analyzed as indicated under Materials and Methods: co-localized signal/infected cell (actin: red; T. gondii: green) or absence of co-localization/by-stander cells (blue). The inset image represents a magnification of the white-dotted square. Data are representative from 4 independent experiments. (F) Mean migrated distances by unchallenged DCs (CM), and challenged non-infected DCs (By-stander) and infected DCs (T. gondii: PTG-GFP type II). Data represent compiled analysis of 500 randomly chosen cells per donor from 4 different donors. Bars indicate mean migrated distances (*: P < 0.05, ns: P > 0.05, Two-way ANOVA, Tukey ́s HSD test). (G) Dot plots represent the distribution of migrated distances for individual DCs infected with T. gondii (type I: LDMluc; type II: PRU-RFP). For each condition, 100 single cells were randomly selected and analyzed from one representative donor. Bar indicates mean migrated distance. Asterisks indicate significant differences (**: P < 0.01; Paired t-test, Holm ́s correction).
Fig 4
Fig 4. Adhesion and migration of Toxoplasma-infected DCs in the presence of integrin-blocking antibodies.
(A) Bar graph shows average number of adhered cells per 100 mm2 (± SD) for unchallenged DCs (CM) and Toxoplasma-challenged DCs (T. gondii, PRU-RFP type II, MOI 3, 4h) as indicated under Materials and Methods (*: P < 0.05; Paired t-test, Holm ́s correction).(B) Bar graphs show the ratio of adhered cells treated with blocking antibodies compared to cells in CM from 3 donors. Unchallenged DCs (left/blue) and DCs challenged with T. gondii (right/red, PRU-RFP, MOI 3, 4h) were exposed to anti-human CD11a, anti-human CD11b, anti-human CD18, anti-human CD29, anti-human CD49b, as indicated under Materials and Methods, for 30 min and seeded on 1% BSA/serum-coated plates (CD11a, CD11b, CD18) or collagen-coated plates (CD29, CD49b). Mouse IgG1 κ Isotype (Isotype M, 10 μg/ml) or Rat IgG2b κ Isotype (Isotype R, 10μg/ml) were used as control antibodies (*: P < 0.05, **: P < 0.01, ***: P < 0.001,Two-way ANOVA, Dunnett ́s test). (C) Mean migrated distances in 3D collagen matrix by cells exposed to blocking antibodies as in (B). Graphs show unchallenged DCs (left/blue) and DCs challenged with T. gondii (right/red, PRU-RFP, MOI 3, 4h). Data represent compiled analysis of 400 cells/donor (± SEM) from 4 donors. (ns: P > 0.05; Two-way ANOVA).
Fig 5
Fig 5. Chemotaxis and hypermigration of Toxoplasma-infected DCs in a 3D matrix.
(A) Schematic representation of the assay set-up with CCL19 added in the lower collagen matrix (dark blue). Cells were deposited onto the upper collagen matrix (light blue) as indicated under Materials and Methods. DCs were maintained in CM, pre-challenged with T. gondii (PRU-RFP, type II) or treated with LPS (final concentration 100 ng/ml) and deposited on top of the collagen layer in 96-well plates. After 24 h incubation, the localization of DAPI-labeled DCs in the gel was analyzed in 200 z-sections. (B) Plots indicate the assembly of z-stacks and colored structures indicate the localization of DCs in absence or presence of CCL19. (C) Dot plots represent the distribution of migrated distances for the different conditions. For each condition, 100 randomly chosen cells were analyzed from one representative donor. Performed with 5 donors with similar result. (D) Mean migrated distances of cells under same conditions as in B and C. Data represent compiled analysis of 500 randomly chosen cells per donor from 5 different donors. Bars indicate mean migrated distances. (*: P < 0.05, ns: P > 0.05; Paired t-test, Holm ́s collection).

References

    1. Hill D, Dubey JP. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect. 2002;8(10):634–40. Epub 2002年10月23日. . - PubMed
    1. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363(9425):1965–76. . - PubMed
    1. Weidner JM, Barragan A. Tightly regulated migratory subversion of immune cells promotes the dissemination of Toxoplasma gondii. Int J Parasitol. 2014;44(2):85–90. Epub 2013年11月05日. 10.1016/j.ijpara.201309006 . - DOI - PubMed
    1. Weidner JM, Kanatani S, Hernandez-Castaneda MA, Fuks JM, Rethi B, Wallin RP, et al. Rapid cytoskeleton remodelling in dendritic cells following invasion by Toxoplasma gondii coincides with the onset of a hypermigratory phenotype. Cell Microbiol. 2013;15(10):1735–52. Epub 2013年03月29日. 10.1111/cmi.12145 . - DOI - PubMed
    1. Lambert H, Hitziger N, Dellacasa I, Svensson M, Barragan A. Induction of dendritic cell migration upon Toxoplasma gondii infection potentiates parasite dissemination. Cellular microbiology. 2006;8(10):1611–23. Epub 2006年09月21日. CMI735 [pii] 10.1111/j.1462-5822.2006.00735.x . - DOI - PubMed
Full text links
Public Library of Science full text link Public Library of Science Free PMC article
Cite

AltStyle によって変換されたページ (->オリジナル) /